Abstract
This is the first case (November 12, 2007) of peri-operative use of zymogen protein C (ZPC) for a heterozygote Protein C deficient (50%) patient with heterozygosity for the prothrombin gene mutation. The surgery involved total left hip replacement. The patient was 74 years of age and at very high-risk for Deep Vein Thrombosis (DVT) thus possible lung emboli. He was a survivor of Venous thrombo-embolism (VTE) in 1999.
For this case the need for increased heparin to prevent a reoccurrence of thrombosis led to a further concern of internal bleeding and possible infection. As proposed by the authors in previous publications the use of a ZPC concentrate would decrease the chance of a thrombosis, with minimum or no internal bleeding. ZPC is activated at the endothelium cell surface and on the surface of the platelets where and when it is needed, therefore providing a safer procedure.
This protocol was implemented by administering ZPC concentrate 1 day prior to surgery and continuing for 10 days after. Slightly higher than normal blood loss occurred, however, a safe procedure was achieved without dangerous side effects while several additional benefits were experienced (level of PC activity as high as 235% above normal were measured during the procedure.). It is felt that positive effects were the result of increased blood flow and oxygen transport to the tissues by reducing blood sludging in the microcirculation. Further studies on Protein C dose levels will be necessary to provide economical, safe and efficacious use of Protein C products.
It is suggested that ZPC should be considered for patients with high probability of VTE which could cause thrombotic occlusion of the pulmonary and peripheral vasculature. These phenomena can result in hypoxia and hypo perfusion causing organ failure and death.
Our research includes a focused effort to optimize upstream and downstream bio-processing to produce both zymogen and activated Protein C at a lower cost and to examine the medical indications that could benefit from a more available and affordable Protein C product.
Keywords
- Deep Vein Thrombosis
- Immobilize Metal Affinity Chromatography
- Internal Bleeding
- Harmful Side Effect
- Prothrombin Gene Mutation
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Andersson, L., 1991, Recognition of phosphate groups by immobilized aluminum (III) ions. J. Chromatogr. 539:327–334.
Andersson, L., Porath, J., 1986, Isolation of phosphoproteins by immobilized metal (Fe+++) affinity chromatography. Anal. Biochem. 154:250–254.
Bertina, R.M., 1988, Protein C and Related Proteins. Churchill Livingstone, New York.
Bicher, H. I., Bruley, D. F., Knisely, M. H., 1973, Anti-adhesive drugs and tissue oxygenation. Adv. Exp. Med. Biol. Plenum Press, 37B:657–667.
Bruley, D.F, 1998, Protein C-The Ultimate Anticoagulant/Antithrombotic?, in: C.A.Thibeault and L.M. Savage (eds.). Anticoagulant, Antithrombotic, and Thrombolytic Thearapeutics II. Springer, Southborough, MA (IBC Library Series).
Bruley, D. F., 2009, Zymogen protein C concentrate for safer heterozygote surgery, “I am a Guinea Pig!”. Adv. Exp. Med. Biol., Oxygen Transport To Tissue XXX, Springer, Vol.645,:115–121.
Bruley, D.F., Drohan, W.N., 1990, Advances in Applied Biotechnology Series, Protein C and related anticoagulants, 11, Gulf Publications, Houston, TX.
Clouse, L.H., Comp, P.C., 1986, The regulation of hemostasis: the Protein C system. N. Engl. J. Med. 314:1298–1304.
Colucci, M., 1984, Influence of protein C activation on blood coagulation and fibrinolysis in squirrel monkeys. J. Clin. Invest. 74:200–204.
Comp, P., Esmon, C., 1981, Generation of fibrinolytic activity by infusion of activated protein C into dogs. J. Clin. Invest. 68:1221–1228.
Dreyfus, M., Magny, J.F. Bridey, F. et al., 1991, Treatment of homologous protein C deficiency and neonatal purpurafulminans with a purified protein C concentrate. N. Engl. J. Med. 325:1565–1568.
Esmon, C. T., 1989, The roles of protein C and thrombomodulin in the regulation of blood coagulation. J. Biol. Chem. 264:4743.
Fernlund, P., Stenflo, J., 1982, Amino acid sequence of the light chain of bovine protein C. J. Biol. Chem. 257:12170–12179.
Gruber, A., Griffin, J.H., Harker, L.A., Hanson, S.R., 1989, Inhibition of platelet-dependent thrombosis formation by human activated protein C in a primate model. Blood. 73:639–642.
Kisiel, W., 1979, Human plasma protein C: Isolation, characterization and mechanism of activation by a thrombin. J. Clin. Invest. 4:761.
Kisiel, W., Carnfield, W. M., Ericsson, L.H., Davie, E. W., 1977, Anticoagulant properties of bovine plasma protein C following activation by thrombin. Biochemistry. 1:5824.
Laemmli, U.K., 1970, Cleavage of the structural proteins during the assembly of the head of bacteriophage T4. Nature. 227:680–685.
Lee, J., Thiessen, E. E., and Bruley, D. F., “Anticoagulant/anti-inflammatory/antithrombotic Protein C Production-Metal Ion/Protein Intefacial Interaction in Immobilized Metal Affinity Chromatography,” Proceeding of the annual ISOTT Conference.
Life Magazine, May 31, 1948.
Manco-Johnson, M., Nuss, R., 1992, Protein C concentrate prevents peripartum thrombosis. Am. J. Hematol. 40:69–70.
Marlar, R. A., Montgomery, R. R., Broakman, A. W., 1989, Diagnosis and treatment of homozygous protein C deficiency. Report of the working party on homozygous protein C deficiency of the subcommittee on protein C and protein S, International Committee on Thrombosis and Haemostasis. J. Paediatrics. 114:528–534.
Odegaard, O. R., Try, K., Anderson, T. R., 1987, Protein C: an automated activity assay. Haemostasis. 17:109–113.
Okajima, K., Koga, S., Kaji, M., et al., 1990, Effect of protein C and activated protein C on coagulation and fibrinolysis on normal human subjects. Thromb. Haemostas. 3:48–53.
Porath, J., 1992, Immobilized metal ion affinity chromatography. Prot. Express. Purif. 3:263–281.
Porath, J., Carlsson, J., Olsson, I., Belfrage, G., 1975, Metal chelate affinity chromatography, a new approach to protein fractionation. Nature. 258:598–599.
Ramadan, N., Porath, J., 1985, Fe3+-hydroxamate as immobilized metal affinity-adsorbent for protein chromatography. J. Chromatogr. 321:93–104.
Sulkowski, E., 1988, Immobilized metal ion affinity of proteins on IDA-Fe3+, Makromol. Chem. Macromol. Symp. 17:335–348.
Tadepalli, S. S., Bruley, D. F., Kang, K. A., Drohan, W. N., 1997, Immobilized metal affinity chromatography process identification and scale-up for protein C production. In: Harrison, D. K., Delpy, D. T. (eds.), ISOTT XIX. Advances in Experimental Medicine and Biology, Vol. 428. Plenum Press, New York, 31–43.
Thiessen, E. E., and D. F. Bruley, 2003 “Theoretical Studies of IMAC Interfacial Phenomena for the Production of Protein C,” Oxygen Transport to Tissue XXV in Adv. Exp. Med. Biol. 540:183.
Velander, W. H., Johnson, J. L., Page, R. L., et. al., 1992, High-level expression of a heterologous protein in the milk of transgenic swine using the cDNA encoding human protein. C. Proc. Natil. Acad. Sci. 89:12003–12007.
Vukovich, T., Auberger, K., Weil, J., Engelmann, H., Knobl, P., Hadorn, H. B., 1988, Replacement therapy for a homozygous protein C deficiency-state using a concentrate of human protein C and S. Br. J. Haematol. 70:435–440.
Winslow, R., 1995, Increased use of blood-thinning drugs could prevent 40,000 strokes a year, Wall St. J. September, 8.
Winzerling, J. J., Patrick, B., Porath, J., 1992, How to use immobilized metal ion affinity chromatography, Methods: Compan. Methods Enzymol. 4:4–13.
Wong, J. W., Albright, R. L., Wang, N. H., 1991, Immobilized metal ion affinity chromatography (IMAC) chemistry and bioseparations applications. Sep. Purif. Methods. 20:49–106.
Wu, H., Bruley, D. F., 1999, Homologous blood protein separation using immobilized metal affinity chromatography – protein C Separation from prothrombin with application to the separation of factor IX and prothrombin. Biotechnol. Prog. 15:928–931.
Wu, H., Bruley, D. F., 2002, Chelator, metal ion and buffer studies for protein C separation. Comp. Biochem. Physiol., A. 132:213–220.
Wu, H., Bruley, D. F., Kang, K. A., 1998, Protein C separation from human blood plasma Cohn fraction IV-1 using immobilized metal affinity chromatography. in: Hudetz, A. G., Bruley, D. F. (eds.), ISOTT XX. Advances in Experimental Medicine and Biology, Vol. 454. Plenum Press, New York, 697–704.
Wu, H., Bruley, D. F., Kang, K. A., Drohan, W. N., 1997, Protein C separation from human plasmas Cohn fraction IV-1 using immobilized metal affinity chromatography, Topical Conference on Separation Science and Technologies – Proceedings of the 1997 Annual AIChE Meeting, 1443–1448.
Yu She,M.Ac.,Lic.Ac.,Dipl.Ac., yshe@umbc.edu, 2007,EllicottCity,MD,USA
Acknowledgments
We want to thank Suzanne Bruley and Eileen Thiessen for the typing and proofing of this manuscript.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2010 Springer Science+Business Media, LLC
About this paper
Cite this paper
Bruley, D.F., Mears, S.C., Streiff, M.B. (2010). Safer Surgery Using Zymogen Protein C Concentrate. In: Takahashi, E., Bruley, D. (eds) Oxygen Transport to Tissue XXXI. Advances in Experimental Medicine and Biology, vol 662. Springer, Boston, MA. https://doi.org/10.1007/978-1-4419-1241-1_63
Download citation
DOI: https://doi.org/10.1007/978-1-4419-1241-1_63
Published:
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4419-1239-8
Online ISBN: 978-1-4419-1241-1
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)